Who's in favor of translational cell therapy for stroke: STEPS forward please?
- Michael Chopp,
- Gary K. Steinberg,
- Douglas Kondziolka,
- Mei Lu,
- Tonya M. Bliss,
- Yi Li
- Henry Ford Health System,
- Stanford University,
- University of Pittsburgh,
- ,
- University of South Florida,
- Medical College of Georgia
Scholary Output:
Contribution to journal
Comment/debate
Peer-review
Open access
Abstract
A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.
Publication Information
Output type
Scholary Output:
Contribution to journal
Comment/debate
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 691-693 (3 pages)Journal (Volume, Issue Number)
Cell Transplantation (Volume 18, Issue 7)Publication milestones
- Published - 2009
Publication status
Published - 2009
ISSN
0963-6897Publication IDs
- Scopus: 70350641323
- PubMed: 19796499
Publication metrics
Metrics
SciVal
citations
39
SciVal
FWCI
7.74
SciVal
Author count
8
SciVal
Paper percentile
86
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Captures
17
Citation count
42
Funding Details
FunderFunding number
NINDS
R01NS055728